RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $791M
1-Year Est. Return 12.81%
This Quarter Est. Return
1 Year Est. Return
+12.81%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$696M
AUM Growth
+$65M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
112
New
Increased
Reduced
Closed

Top Buys

1
+$21M
2
+$13.8M
3
+$10.3M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$7.96M
5
SNY icon
Sanofi
SNY
+$7.67M

Top Sells

1
+$11.2M
2
+$10.8M
3
+$8.62M
4
ESPR icon
Esperion Therapeutics
ESPR
+$8.33M
5
BIIB icon
Biogen
BIIB
+$5.29M

Sector Composition

1 Healthcare 92.59%
2 Financials 0.93%
3 Technology 0.13%
4 Energy 0.1%
5 Consumer Discretionary 0.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$28.8M 4.13%
2,422,090
+670,768
2
$25.9M 3.71%
1,050,000
+420,000
3
$21M 3.02%
+1,216,314
4
$18.7M 2.69%
154,000
+42,298
5
$18.4M 2.65%
142,000
+49,000
6
$18.2M 2.61%
256,916
+50,000
7
$17.6M 2.53%
140,046
+25,046
8
$17.2M 2.47%
189,300
+64,300
9
$17M 2.44%
191,115
+10,000
10
$16.8M 2.41%
363,347
-180,000
11
$16.7M 2.4%
90,000
+25,000
12
$15.5M 2.23%
53,000
+21,667
13
$15.2M 2.18%
106,150
-10,898
14
$14.5M 2.08%
453,665
+100,130
15
$14.3M 2.06%
345,450
+19,650
16
$13.8M 1.98%
+461,654
17
$13.2M 1.9%
85,020
+24,700
18
$13.2M 1.89%
48,500
-19,500
19
$12.6M 1.82%
52,000
-7,000
20
$12.3M 1.77%
150,000
-20,000
21
$12.2M 1.76%
95,013
22
$11.6M 1.66%
92,700
+20,600
23
$11.5M 1.66%
155,118
+42,504
24
$10.3M 1.49%
833,154
+117,490
25
$9.96M 1.43%
156,000
+60,000
1
2 3 4 5